CD4(+)CD25(+) T cells, transplant engraftment, and allospecific tolerance

    Research output: Contribution to journalEditorialpeer-review


    BMT is potentially a cure for hematopoietic disorders; however, the beneficial effects are accompanied by the presence of GVHD. Hanash and Levy have proposed an innovative approach of injection of CD4(+)CD25(+) T cells to prevent GVHD and facilitate donor engraftment while maintaining immune competence
    Original languageEnglish
    Pages (from-to)1375 - 1376
    Number of pages2
    Issue number4
    Publication statusPublished - 2005


    Dive into the research topics of 'CD4(+)CD25(+) T cells, transplant engraftment, and allospecific tolerance'. Together they form a unique fingerprint.

    Cite this